1. Home
  2. STN vs RGEN Comparison

STN vs RGEN Comparison

Compare STN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • RGEN
  • Stock Information
  • Founded
  • STN 1954
  • RGEN 1981
  • Country
  • STN Canada
  • RGEN United States
  • Employees
  • STN N/A
  • RGEN N/A
  • Industry
  • STN Military/Government/Technical
  • RGEN Medical/Dental Instruments
  • Sector
  • STN Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • STN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • STN 9.2B
  • RGEN 7.6B
  • IPO Year
  • STN N/A
  • RGEN N/A
  • Fundamental
  • Price
  • STN $77.47
  • RGEN $156.55
  • Analyst Decision
  • STN
  • RGEN Buy
  • Analyst Count
  • STN 0
  • RGEN 12
  • Target Price
  • STN N/A
  • RGEN $187.44
  • AVG Volume (30 Days)
  • STN 106.2K
  • RGEN 470.1K
  • Earning Date
  • STN 02-26-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • STN 0.80%
  • RGEN N/A
  • EPS Growth
  • STN 6.58
  • RGEN N/A
  • EPS
  • STN 2.27
  • RGEN N/A
  • Revenue
  • STN $4,167,733,814.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • STN $15.93
  • RGEN $2.28
  • Revenue Next Year
  • STN $9.06
  • RGEN $9.88
  • P/E Ratio
  • STN $34.10
  • RGEN N/A
  • Revenue Growth
  • STN 13.64
  • RGEN N/A
  • 52 Week Low
  • STN $74.98
  • RGEN $113.50
  • 52 Week High
  • STN $88.42
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • STN 36.47
  • RGEN 60.07
  • Support Level
  • STN $74.98
  • RGEN $149.15
  • Resistance Level
  • STN $77.09
  • RGEN $160.64
  • Average True Range (ATR)
  • STN 1.15
  • RGEN 5.96
  • MACD
  • STN -0.11
  • RGEN 0.91
  • Stochastic Oscillator
  • STN 47.97
  • RGEN 79.57

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. The company is geographically diversified in three regional operating units namely Canada, United States and Global, offering similar services across all regions. The company offers services in various sectors across the project life cycle through five business operating units infrastructure, water, buildings, environmental services, and energy and resources. The company provides professional services in all phases of the project life cycle: planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: